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Abstract: Diastereoselective Ugi reactions of DMAP-based aldehydes with α-amino acids 
and tert-butyl isocyanide were examined. The reactions of 4-(dimethylamino)-2-pyridine-
carboxaldehyde with various α-amino acids afforded 2-substituted DMAP derivatives with 
low diastereoselectivity. On the contrary, reactions with 4-(dimethylamino)-3-pyridine-
carboxaldehyde delivered 3-substituted DMAP derivatives with moderate to high 
diastereoselectivity. The combination of α-amino acid and DMAP-based aldehyde is thus 
important to achieve high diastereoselectivity. Kinetic resolution of a secondary alcohol 
using a chiral DMAP derivative obtained through these reactions was also examined. 
Keywords: multicomponent reaction; Ugi reaction; chiral DMAP; kinetic resolution 
 
1. Introduction 
Multicomponent reactions are highly efficient in atom economical transformations in synthetic 
organic chemistry [1]. They can be used for constructing various libraries of compounds in medicinal 
chemistry. Among the multicomponent reactions, Ugi reaction, known as a four-component reaction, 
combines a carbonyl compound, an amine, a carboxylic acid, and an isonitrile to afford highly 
functionalized molecules [2,3]. In general, no activator is required and one-pot synthesis is possible. 
Asymmetric variants of the Ugi reaction [4] have been reported using chiral -methylbenzylamines [5-8], 
ferrocenylamines [9-12], glycosylamines [13,14], -amino acids [15-22] and -amino acids [23] to deliver 
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the Ugi adducts with good to high diastereoselectivity. However, the use of a chiral isocyanide [24,25] or 
carboxylic acid [26-28] as the chiral inducer usually confers no asymmetric induction in the Ugi reaction. 
In the course of our research, we have been interested in utilizing an asymmetric Ugi reaction for 
the synthesis of chiral nucleophilic organocatalysts [29]. Among these catalysts, the chiral  
molecule 4-(dimethylamino)pyridine (DMAP) [30] is known as a versatile catalyst for various asymmetric 
transformations, such as kinetic resolution of racemic alcohols [31], desymmetrization of anhydrides [32], 
and inter or intramolecular reactions of oxazolones [33]. However, incorporating a chiral environment 
in the DMAP structure is still a challenging issue because of long synthetic steps required to obtain 
optically pure catalysts. We anticipated that by developing an efficient protocol for the 
diastereoselective Ugi reactions of DMAP-based aldehydes, one-pot synthesis of diverse chiral DMAP 
structures may be easily carried out simply by changing substrate combinations. Furthermore, highly 
functionalized and easily tunable chiral DMAP derivatives are attractive as potential highly active, 
enantioselective catalysts for asymmetric transformation. In this paper, we describe the synthetic 
studies of diastereoselective Ugi reactions using DMAP-based aldehydes and the use of the Ugi 
products as chiral nucleophilic catalysts. 
2. Results and Discussion 
2.1. Diastereoselective Ugi Reaction of 4-(Dimethylamino)-2-pyridinecarboxaldehyde (1) 
We carried out the Ugi reaction of 4-(dimethylamino)-2-pyridinecarboxaldehyde (1), L-valine,  
and tert-butyl isocyanide in MeOH as the solvent and an external nucleophile (U-5C-4CR). We 
speculated that the formation of the new stereogenic center could be controlled by L-valine to afford 
the product as a single diastereomer through simple purification; the product could then be utilized 
directly as a chiral nucleophilic catalyst (chiral DMAP). Because the Ugi reactions of DMAP-based 
aldehydes were not reported, we proceeded with the optimization of the Ugi reaction conditions. 
Because the Ugi reaction is a condensation reaction between organic components, the concentration 
of substrates may be important for obtaining the desired product in reasonable yield. Thus, we 
examined different substrate concentrations for the Ugi reaction (Table 1). The reaction of  
DMAP-based aldehyde 1, L-valine, and tert-butyl isocyanide in MeOH was carried out at room 
temperature for 15 h. Lower concentrations (0.1 and 0.2 M) of 1 delivered the desired product 2a in 
which MeOH was incorporated, even though almost no diastereoselectivity was observed (79% and 
84% yields; entries 1 and 2, respectively). At 0.5 M concentration, the reaction was accelerated 
sufficiently to afford 2a in 98% isolated yield with a 63:37 diastereomeric ratio (d.r.) (entry 3). Higher 
concentration (1.0 M) afforded a yield slightly inferior to that achieved by 0.5 M concentration (91%, 
60:40 d.r.). On the basis of these results, 0.5 M substrate concentration was determined to be optimal 
for the model reaction. 
To improve the diastereoselectivity of the Ugi product, we carried out reactions with various 
-amino acids under the aforementioned conditions. The structure of the -amino acid side chain 
might be important to control the newly formed stereogenic center. 
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Table 1. Ugi reaction of 1 using various substrate concentrations. 
 
Entry Concentration (M) Yield (%) a D.r. b
1 0.1 79 55:45
2 0.2 84 62:38
3 0.5 98 63:37
4 1.0 91 60:40
a Yield of the mixture of diastereomers after column chromatography;  
b Diastereomeric ratio was determined by 1H-NMR analysis of unpurified products. 
As shown in Table 2, we tested various commercially available -amino acids. Reaction with  
L-t-leucine gave the desired product 2b in 70% isolated yield with a 62:38 d.r., thus suggesting that the 
sterically congested side chain of the -amino acid did not improve diastereoselectivity (entry 2 vs. 1). 
Other chiral sources, L-isoleucine, L-phenylalanine, and L-phenylglycine also showed similar 
diastereoselectivities (54%, 57%, 59% yield; 60:40, 55:45, 55:45 d.r.; entries 3–5, respectively). 
Table 2. Ugi reaction of 1 with various -amino acids. 
 
Entry -Amino acid Product Yield (%) a D.r. b 
1 L-Valine  2a 98 63:37 
2 L-t-Leucine  2b 70 62:38 
3 L-Isoleucine 2c 54 60:40 
4 L-Phenylalanine 2d 57 55:45 
5 L-Phenylglycine 2e 59 55:45 
6 L-Threonine  2f 77 50:50 
7 L-Serine  2g 85 53:47 
8 L-Proline 2h 19 51:49 
a Yield of the mixture of diastereomers after column chromatography;  
b Diastereomeric ratio was determined by 1H-NMR analysis of unpurified products. 
Furthermore, the reactions with L-threonine and L-serine, both having a hydroxyl group in the side 
chain, delivered 1:1 mixtures of diastereomers 2f and 2g in good yields. L-Proline, which can generate 
a cyclic iminium intermediate, did not affect diastereotopic selection (19% yield, 51:49 d.r.). 
Unfortunately, the structure of -amino acid had no definite effect on diastereoselectivity of the Ugi 
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products derived from 1. Thus, we decided to use 3-formyl DMAP, a related aldehyde component with 
the intent of improving diastereoselectivity. 
2.2. Diastereoselective Ugi Reaction of 4-(Dimethylamino)-3-pyridinecarboxaldehyde (3) 
Next, we used 4-(dimethylamino)-3-pyridinecarboxaldehyde (3) in the diastereoselective Ugi 
reaction. As shown in Table 3, the Ugi reaction of 3 with L-valine and tert-butyl isocyanide in MeOH 
at 20 °C afforded the Ugi product 4a in 37% isolated yield with an 84:16 d.r. The low yield of 4a is 
assumed to be due to the presence of an adjacent bulky dimethyl amino group, which encumbers the 
formation of the imine or iminium species derived from 3 and L-valine. However, because of the 
reaction of DMAP-based aldehyde 3 and L-valine, large dimethyl amino group might fix imine or 
iminium configuration (E or Z isomer) to avoid steric repulsion against dimethyl amino group. 
Accordingly, a high d.r. could be observed when 3 was used instead 1. To enhance the formation of the 
imine or iminium species, we next carried out the reactions under various reaction temperatures. The 
reaction at 40 °C proceeded to 79% conversion and afforded 4a in 53% yield with a 90:10 d.r. (entry 2). 
Higher conversion (>90%) was achieved at 50 and 60 °C delivering 4a in 57% and 48% isolated yields 
with 89:11 and 85:15 d.r., respectively. According to these results, the reaction at 50 °C is preferred 
considering the yield and diastereoselectivity of the product. Although most of the aldehyde was 
consumed (92% conversion; entry 3), the isolated yield of 4a remained moderate. Owing to this, we 
considered the determination of appropriate substrate ratio of the reaction components (aldehyde, 
-amino acid, and tert-butyl isocyanide) to improve the efficiency of the reaction. 
Table 3. Ugi reaction of 3 at various reaction temperatures. 
 
Entry Temperature (°C) Conversion (%) a Yield (%) b D.r.a 
1 20 50 37 84:16 
2 40 79 53 90:10 
3 50 92 57 89:11 
4 60 97 48 85:15 
a Conversion and diastereomeric ratio were determined by 1H-NMR analysis of 
unpurified products; b Yield of the mixture of diastereomers after column 
chromatography. 
To address the aforementioned issue, the substrate ratio was screened under the previously 
mentioned conditions (Table 4). Although all reactions proceeded in >90% conversion with excess  
L-valine (1.3 and 1.5 equiv.; entries 2 and 3, respectively) and excess tert-butyl isocyanide (1.3 and 1.5 
equiv.; entries 4 and 5), the isolated yield was almost same as that of the control reaction (entry 1). The 
reason for the relatively low isolated yield of the Ugi products with respect to consumption of the 
starting aldehyde is unclear. 
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Table 4. Substrate ratios for diastereoselective Ugi reaction of 3. 
 
Entry X Y Conversion (%) a Yield (%) b D.r.a 
1 1.1 1.1 91 54 91:9 
2 1.3 1.1 94 55 89:11 
3 1.5 1.1 97 55 89:11 
4 1.1 1.3 96 59 89:11 
5 1.1 1.5 95 57 85:15 
a Conversion and diastereomeric ratio were determined by 1H-NMR analysis of 
unpurified products; b Yield of the mixture of diastereomers after column 
chromatography. 
Considering a relatively effective diastereoselective Ugi reaction of DMAP-based aldehyde 3, 
various -amino acids were investigated under the optimized reaction conditions (Table 5). Reactions 
with -amino acids bearing alkyl side chains led to the corresponding products in moderate yield with 
good to high diastereoselectivity (45%–63%; 59:41–93:7 d.r; entries 1 and 4–8). Ciufolini reported that 
Ugi reactions of aromatic aldehydes, -amino acids and t-BuNC in MeOH with TiCl4 as a catalyst 
showed improved isolated yields of Ugi product [22]. TiCl4 was thus added to the reaction mixture, 
however the result was almost identical to that obtained under the uncatalyzed reaction (entry 2 vs. 1). 
Furthermore, using MgSO4 as a dehydrating agent resulted in slightly decreasing in isolated yield and 
diastereoselectivity (entry 3 vs. 1). Side chains having a heteroatom also showed the same results as 
those of their alkyl counterparts (entries 9–16). It is surprising that the d.r. of the Ugi products was not 
dramatically changed by modifying the structure of -amino acid. Furthermore, the reaction 
proceeding through the cyclic iminium intermediate derived from L-proline and aldehyde 3 did not 
improve both yield and diastereoselectivity (51% yield; 74:26 d.r.; entry 17). The stereochemistry of 
major diastereomer 4a was determined by X-ray structure analysis, showing R configuration at newly 
formed stereogenic center (Figure 1). The absolute configuration of the major product was different 
from related reaction reported by Ciufolini [22]. 
Table 5. Ugi reaction of 3 with various -amino acids. 
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Table 5. Cont. 
Entry -Amino acid Product Yield a D.r. b 
1 L-Valine  4a 55 92:8 
2 c L-Valine 4a 57 88:12 
3 d L-Valine 4a 46 85:15 
4 L-Leucine 4b 63 86:14 
5 L-t-Leucine 4c 52 89:11 
6 L-Isoleucine 4d 55 93:7 
7 L-Phenylalanine 4e 60 88:12 
8 L-Phenylglycine 4f 45 59:41 
9 L-Serine 4g 43 77:23 
10 L-Methionine 4h 58 83:17 
11 O-t-Butyl L-threonine 4i 63 82:18 
12 γ-Methyl L-glutamate 4j 47 83:17 
13 4-Benzyl L-aspartate 4k 52 79:21 
14 O-Benzyl L-serine 4l 54 75:25 
15 L-Histidine  4m 44 77:23 
16 e N-Benzyl L-valine 4n 18 92:8 
17 L-Proline 4o 51 74:26 
a Yield of the mixture of diastereomer after column chromatography; b Diastereomeric ratio was 
determined by 1H-NMR analysis of unpurified products; c 20 mol % of TiCl4 was added; d The 
suspension of the aldehyde, -amino acid, and MgSO4 were stirred for 3 h at room temperature 
before the addition of t-BuNC; e Reaction time was 48 h. 
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Figure 1. X-ray structure of major diastereomer of 4a; disordered atoms omitted for clarity. 
 
2.3. Kinetic Resolution of a Racemic Alcohol by Chiral DMAP Derivatives 
Next, we explored the possibility of using Ugi products as chiral nucleophilic catalysts. The kinetic 
resolution of racemic alcohol was selected as a model study. A major diastereomer of Ugi product 4a, 
which can be easily obtained by column chromatography, was utilized as the catalyst in toluene at 
−60 °C (Scheme 1). The selectivity factor [34], which was estimated by ee of acetylated product 6 and 
unreacted alcohol 5 [35], was indicated to be 2.33. It was noted that the Ugi product 4a was capable of 
catalyzing the acylation reaction, although the selectivity was not satisfied at the moment. Further 
study to develop more efficient catalysts is now under way. 
Scheme 1. Kinetic resolution of rac-5 using major diastereomer of 4a. 
 
3. Experimental 
3.1. General 
All melting points were determined using a Yanaco micro melting point apparatus MP-S3 and are 
uncorrected. Solvents were generally distilled and dried by standard literature procedures prior to use. 
The IR spectra were recorded on a JASCO FT/IR-4100 spectrometer. NMR spectra were recorded on a 
Varian VNMRS-400 spectrometer at SC-NMR Laboratory (Okayama University), operating at  
400 MHz for 1H-NMR and 100 MHz for 13C-NMR. Chemical shifts in CDCl3 were reported in the  
scale relative to CHCl3 (7.26 ppm) as an internal reference for 1H-NMR. For 13C-NMR, chemical 
shifts were reported in the scale relative to CHCl3 (77.0 ppm) as an internal reference. Column 
chromatography was performed with silica gel 60 N (spherical, neutral, 40–50 m) purchased from 
Kanto Chemical. Optical rotations were measured on a Horiba Model SEPA-300 High-sensitive 
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polarimeter. FAB mass spectra (for HRMS) were measured on a JEOL JMS-700 MStation at the Mass 
Spectrometry Facility (Okayama University). The enantiomeric excess (ee) was determined by HPLC 
analysis. HPLC was performed on Shimadzu HPLC systems consisting of the following: pump, LC-10AD; 
detector, SPD-10A, 254 nm; column, Daicel Chiracel OD-H; mobile phase, hexane/2-propanol. 
3.2. General Procedure for the Ugi Reaction of 4-(Dimethylamino)-2-pyridinecarboxaldehyde (1) 
To a suspension of L-valine (23.1 mg, 0.20 mmol) and aldehyde 1 (36.6 mg, 0.24 mmol) in dry 
methanol (0.4 mL) in a screw-cap test tube, tert-butyl isocyanide (17.2 mg, 0.21 mmol) was added and 
the reaction mixture was stirred for 15 h at room temperature. The solvent was evaporated in vacuo 
and the resulting residue was purified by silica gel column chromatography (EtOAc/Et3N = 97:3, v/v) 
to give (1R) N-(1-(N-tert-butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-2-yl)methyl)-L-valine methyl 
ester (2a) as a brown gummy oil (70.5 mg, 98% yield, d.r. 63:37). For mixture of two diastereomers: 
IR (neat) = 3327, 2964, 1738, 1681, 1603 cm–1; 1H-NMR (CDCl3, major diastereomer)  1.03 (d,  
J = 6.0 Hz, 6H), 1.32 (s, 9H), 2.03 (sext, J = 6.8 Hz, 1H), 2.03 (br, 1H), 2.97 (s, 6H), 3.02–3.07 (m, 
1H), 3.60 (s, 3H), 3.90 (s, 1H), 6.39 (dd, J = 2.6, 6.0 Hz, 1H), 6.69 (d, J = 2.6 Hz, 1H), 7.60 (br, 1H), 
8.14 (d, J = 6.0 Hz, 1H); 13C-NMR (CDCl3, major diastereomer)  18.4, 19.9, 28.6, 31.5, 39.1, 50.5, 
51.5, 65.8, 66.8, 105.1, 105.8, 148.6, 154.6, 156.8, 171.0, 174.9; HRMS-FAB (m/z): [M+H]+ calcd. for 
C19H33N4O3 365.2553, found 365.2535. 
(1SR) N-(1-(N-tert-Butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-2-yl)methyl)-L-t-leucine methyl ester 
(2b): A pale yellow oil (53.6 mg, 70% yield, d.r. 62:38); For mixture of two diastereomers: IR (neat) 
= 3337, 2965, 1732, 1674, 1604 cm–1; 1H-NMR (CDCl3, major diastereomer)  1.04 (s, 9H), 1.32 (s, 
9H), 2.57 (br, 1H), 2.95 (br, 1H), 2.97 (s, 6H), 3.58 (s, 3H), 3.81 (s, 1H), 6.38 (dd, J = 2.4, 6.0 Hz, 
1H), 6.66 (d, J = 2.4 Hz, 1H), 7.57 (br, 1H), 8.15 (d, J = 6.0 Hz, 1H); 13C-NMR (CDCl3, major 
diastereomer)  26.9, 28.6, 34.2, 39.1, 50.5, 51.1, 67.4, 70.1, 105.1, 105.8, 148.6, 154.6, 156.7, 170.8, 
174.5; HRMS-FAB (m/z): [M+H]+ calcd. for C20H35N4O3 379.2709, found 379.2739. 
(1SR) N-(1-(N-tert-Butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-2-yl)methyl)-L-isoleucine methyl ester 
(2c): A pale yellow oil (40.5 mg, 54% yield, d.r. 60:40); For mixture of two diastereomers: IR (neat) 
= 2967, 1733, 1673, 1604 cm–1; 1H-NMR (CDCl3, major diastereomer)  0.91 (t, J = 7.4 Hz, 3H), 
0.97 (d, J = 6.8 Hz, 3H), 1.31 (s, 9H), 1.55–1.67 (m, 1H), 1.74–1.84 (m, 1H), 2.35 (br, 1H), 2.97 (s, 
6H), 3.02–3.06 (m, 1H), 3.15 (d, J = 6.0 Hz, 1H), 3.59 (s, 3H), 3.90 (s, 1H), 6.38 (dd, J = 2.4, 6.0 Hz, 
1H), 6.68 (d, J = 2.4 Hz, 1H), 7.60 (br, 1H), 8.14 (d, J = 6.0 Hz, 1H); 13C-NMR (CDCl3, major 
diastereomer)  11.4, 16.2, 25.2, 28.6, 38.2, 39.1, 50.5, 51.5, 65.5, 67.2, 105.1, 105.8, 148.5, 154.6, 
156.8, 171.0, 174.8; HRMS-FAB (m/z): [M+H]+ calcd. for C20H35N4O3 379.2709, found 379.2703. 
(1SR) N-(1-(N-tert-Butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-2-yl)methyl)-L-phenylalanine methyl 
ester (2d): A pale yellow oil (45.6 mg, 57% yield, d.r. 55:45); For mixture of two diastereomers: IR 
(neat) = 2964, 1739, 1676, 1604 cm–1; 1H-NMR (CDCl3, major diastereomer)  1.09 (s, 9H), 2.81–2.92 
(m, 1H), 2.96 (s, 6H), 3.01–3.08 (m, 2H), 3.48–3.54 (m, 1H), 3.57 (s, 3H), 3.95 (s, 1H), 6.38 (dd,  
J = 2.4, 5.6 Hz, 1H), 6.67 (d, J = 2.4 Hz, 1H), 7.12 (br, 1H), 7.14–7.31 (m, 5H), 8.14 (d, J = 5.6 Hz, 
1H); 13C-NMR (CDCl3, major diastereomer)  28.3, 39.1, 39.8, 50.2, 51.7, 62.6, 66.5, 105.0, 105.7, 
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126.6, 128.5, 129.3, 137.9, 148.5, 154.6, 156.7, 170.6, 174.5; HRMS-FAB (m/z): [M+H]+ calcd. for 
C23H33N4O3 413.2553, found 413.2551. 
(1SR) N-(1-(N-tert-Butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-2-yl)methyl)-L-phenylglycine methyl 
ester (2e): A pale yellow oil (47.6 mg, 59% yield, d.r. 55:45); For mixture of two diastereomers: IR 
(neat) = 2916, 1739, 1673, 1604 cm–1; 1H-NMR (CDCl3, major diastereomer)  1.22 (s, 9H), 2.04 (s, 
1H), 3.02 (s, 6H), 3.65 (s, 3H), 4.10 (br, 1H), 4.36 (s, 1H), 6.42 (dd, J = 2.8, 6.0 Hz, 1H), 6.74 (d,  
J = 2.8 Hz, 1H), 7.25–7.38 (m, 5H), 7.46 (br, 1H), 8.15 (d, J = 6.0 Hz, 1H); 13C-NMR (CDCl3, major 
diastereomer)  28.5, 39.2, 50.7, 52.3, 64.3, 65.5, 105.1, 105.7, 127.8, 128.2, 128.8, 129.8, 137.9, 
155.1, 157.0, 170.0, 172.8; HRMS-FAB (m/z): [M+H]+ calcd. for C22H31N4O3 399.2396, found 399.2409. 
(1SR) N-(1-(N-tert-Butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-2-yl)methyl)-L-threonine methyl ester 
(2f): A pale yellow oil (61.7 mg, 77% yield, d.r. 50:50); For mixture of two diastereomers: IR (neat) 
= 3329, 2972, 1737, 1673, 1604 cm–1; 1H-NMR (CDCl3, major diastereomer)  1.17 (d, J = 6.4 Hz, 
3H), 1.30 (s, 9H), 1.98 (br, 1H), 3.01 (s, 6H), 3.14 (d, J = 6.4 Hz, 1H), 3.65 (s, 3H), 3.95 (quin, J = 6.4 Hz, 
1H), 4.19 (s, 1H), 4.54 (br, 1H), 6.41 (dd, J = 2.4, 6.0 Hz, 1H), 6.68 (d, J = 2.4 Hz, 1H), 7.48 (br, 1H), 
8.14 (d, J = 6.0 Hz, 1H); 13C-NMR (CDCl3, major diastereomer)  19.7, 22.7, 28.5, 39.2, 50.9, 52.0, 
66.3, 68.0, 105.1, 105.8, 147.3, 155.2, 156.2, 169.8, 173.5; HRMS-FAB (m/z): [M+H]+ calcd. for 
C18H31N4O4 367.2345, found 367.2319. 
(1SR) N-(1-(N-tert-Butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-2-yl)methyl)-L-serine methyl ester 
(2g): A pale yellow oil (60.3 mg, 85% yield, d.r. 53:47); For mixture of two diastereomers: IR (neat) 
= 3329, 2969, 1739, 1671, 1604 cm–1; 1H-NMR (CDCl3, major diastereomer)  1.30 (s, 9H), 2.99 (s, 
6H), 3.43 (br, 1H), 3.47–3.50 (m, 1H), 3.66 (s, 3H), 3.75–3.78 (m, 1H), 3.82 (d, J = 4.2 Hz, 1H), 4.21 
(s, 1H), 4.38 (br, 1H), 6.39 (dd, J = 2.8, 6.0 Hz, 1H), 6.70 (d, J = 2.8 Hz, 1H), 7.52 (br, 1H), 8.10 (d,  
J = 6.0 Hz, 1H); 13C-NMR (CDCl3, major diastereomer)  28.4, 39.1, 50.8, 52.1, 61.8, 62.3, 65.1, 
104.9, 105.6, 147.7, 155.2, 156.8, 170.3, 172.8; HRMS-FAB (m/z): [M+H]+ calcd. for C17H29N4O4 
353.2189, found 353.2200. 
Procedure for the Synthesis of 2h 
To the mixture of L-proline (33.9 mg, 0.29 mmol) and aldehyde 1 (39.8 mg, 0.27 mmol) in dry 
methanol (0.4 mL) in a screw-cap test tube, tert-butyl isocyanide (30.4 L, 0.27 mmol) was added and 
the reaction mixture was stirred for 24 h at room temperature. The solvent was evaporated in vacuo. To 
a solution of the crude product in MeOH (4 mL) was added NaBH4 (31.6 mg, 0.84 mmol) at 0 °C 
owing to reduction of unreacted aldehyde 1. The reaction mixture was stirred at the same temperature 
for one hour before being quenched with saturated aq. NH4Cl (4 mL). The resulting solution was 
warmed to room temperature and extracted with Et2O (3 × 4 mL). The combined organic phase was 
washed with brine (15 mL), dried over MgSO4, filtered, and concentrated in vacuo to give (1SR) N-(1-
(N-tert-butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-2-yl)methyl)-L-proline methyl ester (2h) as a 
pale yellow oil (18.0 mg, 19% yield, d.r. 51:49). For mixture of two diastereomers: IR (neat) = 2967, 
1737, 1671, 1603 cm–1; 1H-NMR (CDCl3)  1.31 (s, 9H), 1.37 (s, 9H), 1.78–1.89 (m, 6H), 2.07–2.17 
(m, 2H), 2.68–2.81 (m, 2H), 2.98 (s, 6H), 2.99 (s, 6H), 3.09–3.15 (m, 2H), 3.57 (s, 3H), 3.63 (s, 3H), 
Molecules 2011, 16 8824 
 
3.65–3.69 (m, 2H), 4.22 (s, 2H), 6.38 (dd, J = 2.8, 6.0 Hz, 1H), 6.39 (dd, J = 2.8, 6.0 Hz, 1H), 6.51 (d, 
J = 2.8 Hz, 1H), 6.54 (d, J = 2.8 Hz, 1H), 7.38 (br, 1H), 7.93 (br, 1H), 8.15 (d, J = 6.0 Hz, 1H), 8.17 
(d, J = 6.0 Hz, 1H); 13C-NMR (CDCl3)  23.6, 23.7, 28.5, 28.6, 29.9, 30.4, 39.1, 39.1, 50.6, 50.7, 50.9, 
51.4, 51.5, 52.7, 61.6, 62.9, 74.2, 74.8, 105.6, 105.7, 106.6, 107.1, 149.0, 149.1, 154.7, 154.8, 156.5, 
157.1, 170.0, 170.2, 175.4, 175.9; HRMS-FAB (m/z): [M+H]+ calcd. for C19H31N4O3 363.2396,  
found 363.2391. 
3.3. General Procedure for the Ugi Reaction of 4-(Dimethylamino)-3-pyridinecarboxaldehyde (3) 
To the suspension of aldehyde 3 (75.1 mg, 0.50 mmol) and L-valine (64.4 mg, 0.55 mmol) in dry 
methanol (1.0 mL) in a screw-cap test tube, tert-butyl isocyanide (62.0 L, 0.55 mmol) was added and 
the reaction mixture was stirred for 15 hours at 50 °C. The solvent was evaporated in vacuo and the 
resulting residue was purified by silica gel column chromatography on SiO2 (EtOAc/toluene = 4:1, 
v/v) to give (1R) N-(1-(N-tert-butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-3-yl)methyl)-L-valine 
methyl ester (4a) as a colorless solid (99.7 mg, 55% yield, d.r. 92:8, Table 5, entry 1). For the major 
diastereomer: m.p. 119 °C; IR (KBr) = 3200, 2963, 1737, 1673 cm–1; 1H-NMR (CDCl3)  0.85 (d,  
J = 6.7 Hz, 3H), 0.90 (d, J = 6.7 Hz, 3H), 1.34 (s, 9H), 1.92 (sext, J = 6.7 Hz, 1H), 2.40 (br, 1H), 2.79 
(br, 1H), 2.85 (s, 6H), 3.70 (s, 3H), 4.58 (s, 1H), 6.88 (d, J = 5.6 Hz, 1H), 7.26 (br, 1H), 8.36 (d,  
J = 5.6 Hz, 1H), 8.48 (s, 1H); 13C-NMR (CDCl3)  18.4, 19.1, 28.6, 31.3, 44.3, 50.8, 51.5, 58.8, 64.8, 
113.6, 127.9, 149.8, 150.3, 159.4, 170.9, 174.6; HRMS-FAB (m/z): [M+H]+ calcd. for C19H33N4O3 
365.2553, found 365.2554; []D25 –137 (c 0.715, MeOH). 
(1R) N-(1-(N-tert-Butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-3-yl)methyl)-L-leucine methyl ester 
(4b): A colorless solid (118.6 mg, 63% yield, d.r. 86:14); For the major diastereomer: m.p. 139–141 °C;  
IR (KBr) = 3372, 3210, 2952, 1734, 1666 cm–1; 1H-NMR (CDCl3)  0.72 (d, J = 6.6 Hz, 3H), 0.85 (d, 
J = 6.6 Hz, 3H), 1.35 (s, 9H), 1.42–1.45 (m, 2H), 1.61 (sext, J = 6.6 Hz, 1H), 2.13 (br, 1H, 2.84 (s, 
6H), 3.03–3.07 (m, 1H), 3.68 (s, 3H), 4.58 (s, 1H), 6.87 (d, J = 5.5 Hz, 1H), 7.37 (br, 1H), 8.35 (d,  
J = 5.5 Hz, 1H), 8.42 (s, 1H); 13C-NMR (CDCl3)  21.7, 22.9, 24.7, 28.6, 42.3, 44.3, 50.9, 51.8, 57.8, 
59.0, 113.6, 128.3, 149.9, 150.1, 159.4, 171.0, 175.3; HRMS-FAB (m/z): [M+H]+ calcd. for 
C20H35N4O3 379.2709, found 379.2702; []D25 –148 (c 0.205, MeOH). 
(1R) N-(1-(N-tert-Butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-3-yl)methyl)-L-t-leucine methyl ester 
(4c): A colorless solid (39.6 mg, 52% yield, d.r. 89:11); For the major diastereomer: m.p. 165–166 °C; 
IR (KBr) = 3353, 3214, 2965, 1737, 1677 cm–1; 1H-NMR (CDCl3)  0.91 (s, 9H), 1.32 (s, 9H),  
2.57–2.66 (m, 2H), 2.84 (s, 6H), 3.68 (s, 3H), 4.49 (s, 1H), 6.89 (d, J = 5.5 Hz, 1H), 7.07 (br, 1H), 8.37 
(d, J = 5.5 Hz, 1H), 8.50 (s, 1H); 13C-NMR (CDCl3)  26.7, 28.7, 34.0, 44.3, 50.8, 51.2, 58.8, 67.7, 
113.7, 127.5, 149.9, 150.5, 159.6, 170.8, 174.5; HRMS-FAB (m/z): [M+H]+ calcd. for C20H35N4O3 
379.2709, found 379.2733; []D25 –146 (c 0.270, MeOH). 
(1R) N-(1-(N-tert-butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-3-yl)methyl)-L-isoleucine methyl ester 
(4d): A colorless solid (104.3 mg, 55% yield, d.r. 93:7); For the major diastereomer: m.p. 97–100 °C; 
IR (KBr) = 3333, 3204, 2967, 1739, 1676 cm–1; 1H-NMR (CDCl3)  0.79 (d, J = 7.7 Hz, 3H), 0.80  
(t, J = 7.7 Hz, 3H), 1.06–1.17 (m, 1H), 1.32 (s, 9H), 1.43–1.49 (m, 1H), 1.63–1.69 (m, 1H), 2.37 (br, 
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1H), 2.83 (s, 6H), 2.86 (d, J = 6.0 Hz, 1H), 3.68 (s, 3H), 4.55 (s, 1H), 6.87 (d, J = 5.6 Hz, 1H), 7.25 
(br, 1H), 8.34 (d, J = 5.6 Hz, 1H), 8.45 (s, 1H); 13C-NMR (CDCl3)  11.2, 15.5, 25.2, 28.6, 37.9, 44.3, 
50.8, 51.5, 58.9, 63.8, 113.7, 128.0, 149.8, 150.3, 159.4, 170.9, 174.6; HRMS-FAB (m/z): [M+H]+ 
calcd. for C20H35N4O3 379.2709, found 379.2713; []D25 –115 (c 0.325, MeOH). 
(1SR) N-(1-(N-tert-Butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-3-yl)methyl)-L-phenylalanine methyl 
ester (4e): A colorless solid (123.3 mg, 60% yield, d.r. 88:12); For mixture of two diastereomers: m.p. 
128–129 °C; IR (KBr) = 3319, 3202, 2962, 1739, 1673 cm–1; 1H-NMR (CDCl3, major diastereomer) 
 1.31 (s, 9H), 2.27 (br, 1H), 2.74 (s, 6H), 2.83 (dd, J = 7.9, 13.7 Hz, 1H), 2.97 (dd, J = 5.9, 13.7 Hz, 
1H), 3.32–3.36 (m, 1H), 3.64 (s, 3H), 4.58 (s, 1H), 6.81 (d, J = 5.6 Hz, 1H), 7.02–7.04 (m, 2H), 7.18–7.26 
(m, 3H), 7.41 (br, 1H), 8.20 (s, 1H), 8.31 (d, J = 5.6 Hz, 1H); 13C-NMR (CDCl3, major diastereomer)  
28.6, 38.9, 44.3, 50.7, 51.8, 58.8, 60.7, 113.6, 126.8, 127.9, 128.5, 128.9, 136.6, 149.8, 150.0, 159.2, 
170.8, 173.9; HRMS-FAB (m/z): [M+H]+ calcd. for C23H33N4O3 413.2553, found 413.2532. 
(1SR) N-(1-(N-tert-Butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-3-yl)methyl)-L-phenylglycine methyl 
ester (4f): A colorless solid (90.0 mg, 45% yield, d.r. 59:41); For mixture of two diastereomers: m.p. 
146–149 °C; IR (KBr) = 3195, 2995, 1738, 1666 cm–1; 1H-NMR (CDCl3, major diastereomer)  1.39 
(s, 9H), 1.75 (br, 1H), 2.62 (s, 6H), 3.69 (s, 3H), 4.29 (br, 1H), 4.43 (s, 1H), 6.79 (d, J = 5.6 Hz, 1H), 
7.30–7.40 (m, 5H), 7.43 (br, 1H), 8.31 (d, J = 5.6 Hz, 1H), 8.40 (s, 1H); 13C-NMR (CDCl3, major 
diastereomer)  28.7, 43.9, 51.0, 52.4, 57.9, 64.0, 113.6, 127.8, 128.5, 128.7, 128.9, 137.2, 149.7, 
149.8, 158.9, 170.6, 172.4; HRMS-FAB (m/z): [M+H]+ calcd. for C22H31N4O3 399.2396, found 399.2382. 
(1SR) N-(1-(N-tert-Butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-3-yl)methyl)-L-serine methyl ester 
(4g): A yellowish solid (76.2 mg, 43% yield, d.r. 77:23); For mixture of two diastereomers: m.p. 121 °C; 
IR (KBr) = 3451, 3202, 2959, 1722, 1666 cm–1; 1H-NMR (CDCl3, major diastereomer)  1.35 (s, 
9H), 2.86 (br, 1H), 2.86 (s, 6H), 3.29 (dd, J = 4.4, 5.3 Hz, 1H), 3.70–3.72 (m, 1H), 3.74 (s, 3H), 3.79–3.85 
(m, 1H), 4.71 (s, 1H), 6.92 (d, J = 5.6 Hz, 1H), 7.28 (br, 1H), 8.36 (d, J = 5.6 Hz, 1H), 8.43 (s, 1H); 
13C-NMR (CDCl3, major diastereomer)  28.6, 44.5, 51.1, 52.2, 58.5, 61.0, 62.5, 114.0, 128.5, 149.7, 
149.8, 159.3, 170.7, 172.7; HRMS-FAB (m/z): [M+H]+ calcd. for C17H29N4O4 353.2189, found 
353.2175. 
(1R) N-(1-(N-tert-Butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-3-yl)methyl)-L-methionine methyl ester 
(4h): A colorless solid (115.0 mg, 58% yield, d.r. 83:17). For the major diastereomer: m.p. 98–100 °C; 
IR (KBr) = 3203, 2971, 1735, 1671 cm–1; 1H-NMR (CDCl3)  1.26 (s, 9H), 1.70–1.79 (m, 1H), 
1.83–1.91 (m, 1H), 1.95 (s, 3H), 2.34–2.49 (m, 2H), 2.35 (br, 1H), 2.77 (s, 6H), 3.14 (br, 1H), 3.63 (s, 
3H), 4.57 (s, 1H), 6.82 (d, J = 5.5 Hz, 1H), 7.18 (br, 1H), 8.28 (d, J = 5.5 Hz, 1H), 8.39 (s, 1H);  
13C-NMR (CDCl3)  15.2, 28.5, 30.3, 32.2, 44.2, 50.7, 51.8, 58.0, 58.4, 113.6, 128.0, 149.8, 150.0, 
159.1, 170.6, 174.2; HRMS-FAB (m/z): [M+H]+ calcd. for C19H33N4O3S 397.2273, found 397.2245; 
[]D25 −156 (c 0.420, MeOH). 
(1SR) N-(1-(N-tert-Butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-3-yl)methyl) O-t-butyl L-threonine 
methyl ester (4i): A colorless solid (132.6 mg, 63% yield, d.r. 82:18); For mixture of two diastereomers: 
m.p. 136 °C; IR (KBr) = 3387, 3249, 2977, 1732, 1675 cm–1; 1H-NMR (CDCl3, major diastereomer) 
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 1.05 (s, 9H), 1.08 (d, J = 6.2 Hz, 3H), 1.35 (s, 9H), 2.20 (br, 1H), 2.54 (br, 1H), 2.84 (s, 6H), 3.68 (s, 
3H), 3.86 (td, J = 6.2, 10.7 Hz, 1H), 4.65 (s, 1H), 6.84 (d, J = 5.6 Hz, 1H), 7.55 (br, 1H), 8.31 (d,  
J = 5.6 Hz, 1H), 8.40 (s, 1H); 13C-NMR (CDCl3, major diastereomer)  20.5, 28.3, 28.6, 44.4, 50.8, 
51.7, 59.1, 65.5, 68.2, 74.0, 113.5, 128.2, 149.7, 149.9, 159.5, 171.3, 173.5; HRMS-FAB (m/z): 
[M+H]+ calcd. for C22H39N4O4 423.2971, found 423.2973. 
(1SR) N-(1-(N-tert-Butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-3-yl)methyl) L-glutamic acid dimethyl 
ester (4j): A colorless solid (94.9 mg, 47% yield, d.r. 83:17); For the major diastereomer: m.p. 89–90 °C; 
IR (KBr) = 3202, 2970, 1740, 1672 cm–1; 1H-NMR (CDCl3)  1.34 (s, 9H), 1.82–2.02 (m, 2H), 2.30 
(br, 1H), 2.35 (t, J = 7.6 Hz, 2H), 2.84 (s, 6H), 3.04 (dd, J = 5.8, 7.6 Hz, 1H), 3.63 (s, 3H), 3.70  
(s, 3H), 4.64 (s, 1H), 6.88 (d, J = 5.6 Hz, 1H), 7.11 (br, 1H), 8.36 (d, J = 5.6 Hz, 1H), 8.43 (s, 1H);  
13C-NMR (CDCl3)  27.9, 28.7, 30.2, 44.4, 51.0, 51.7, 52.0, 58.2, 58.3, 113.7, 127.9, 149.9, 150.0, 
159.5, 170.7, 173.2, 174.2; HRMS-FAB (m/z): [M+H]+ calcd. for C20H33N4O5 409.2451, found 
409.2426; []D25 −156 (c 0.120, MeOH). 
(1SR) -Benzyl N-(1-(N-tert-butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-3-yl)methyl)-L-aspartic acid 
methyl ester (4k): A colorless solid (122.5 mg, 52% yield, d.r. 79:21); For mixture of two 
diastereomers: m.p. 105 °C; IR (KBr) = 3334, 3202, 2971, 1739, 1668 cm–1; 1H-NMR (CDCl3, 
major diastereomer)  1.34 (s, 9H), 1.98 (br, 1H), 2.75 (dd, J = 3.0, 6.1 Hz, 2H), 2.81 (s, 6H), 3.52 (br, 
1H), 3.66 (s, 3H), 4.67 (s, 1H), 5.06 (dd, J =12.2, 18.4 Hz, 2H), 6.87 (d, J = 5.5 Hz, 1H), 7.27–7.36 (m, 
5H), 7.40 (br, 1H), 8.36 (d, J = 5.5 Hz, 1H), 8.41 (s, 1H); 13C-NMR (CDCl3, major diastereomer) 
 28.6, 36.9, 44.4, 50.9, 52.2, 56.0, 58.4, 66.6, 113.9, 128.3, 128.3, 128.4, 128.5, 135.4, 150.0,  
150.0, 159.2, 170.4, 170.7, 172.8; HRMS-FAB (m/z): [M+H]+ calcd. for C25H35N4O5 471.2607,  
found 471.2593. 
(1SR) N-(1-(N-tert-Butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-3-yl)methyl) O-benzyl L-serine methyl 
ester (4l): A colorless solid (120.2 mg, 54% yield, d.r. 75:25); For mixture of two diastereomers: m.p. 
145 °C; IR (KBr) = 3203, 2969, 1743, 1667 cm–1; 1H-NMR (CDCl3, major diastereomer)  1.36 (s, 
9H), 1.74 (br, 1H), 2.80 (s, 6H), 3.33 (br, 1H), 3.52–3.65 (m, 2H), 3.71 (s, 3H), 4.41 (dd, J = 12.2, 14.3 
Hz, 2H), 4.69 (s, 1H), 6.86 (d, J = 5.6 Hz, 1H), 7.17–7.19 (m, 2H), 7.24–7.37 (m, 3H), 7.57 (br, 1H), 
8.35 (d, J = 5.6 Hz, 1H), 8.41 (s, 1H); 13C-NMR (CDCl3, major diastereomer)  28.7, 44.4, 50.9, 52.1, 
59.0, 59.6, 70.1, 73.1, 113.8, 127.6, 127.8, 128.4, 128.5, 137.5, 149.8, 150.0, 159.4, 171.0, 172.4; 
HRMS-FAB (m/z): [M+H]+ calcd. for C24H35N4O4 443.2658, found 443.2681. 
(1SR) N-(1-(N-tert-Butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-3-yl)methyl)-L-histidine methyl ester 
(4m): A colorless solid (88.1 mg, 44% yield, d.r. 77:23); For mixture of two diastereomers: m.p.  
110–113 °C; IR (KBr) = 3320, 3206, 2960, 1741, 1676 cm–1; 1H-NMR (CDCl3, major diastereomer) 
 1.33 (s, 9H), 2.55 (br, 1H), 2.81 (s, 6H), 2.86–3.06 (m, 2H), 3.42 (dd, J = 5.1, 7.6 Hz, 1H), 3.70 (s, 
3H), 4.65 (s, 1H), 6.67 (s, 1H), 6.86 (d, J = 5.6 Hz, 1H), 7.44 (s, 1H), 7.46 (br, 1H), 8.23 (s, 1H), 8.29 
(d, J = 5.6 Hz, 1H); 13C-NMR (CDCl3, major diastereomer)  28.6, 28.6 30.1, 44.3, 44.4, 50.9, 52.1, 
58.7, 59.7, 113.7, 128.5, 135.1, 149.5, 149.6, 159.4, 171.0, 174.0; HRMS-FAB (m/z): [M+H]+ calcd. 
for C20H31N6O3 403.2458, found 403.2460. 
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(1SR) N-Benzyl-(1-(N-tert-butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-3-yl)methyl)-L-valine methyl 
ester (4n): A colorless syrup (15.9 mg, 18% yield, d.r. 92:8); For mixture of two diastereomers: IR 
(KBr) = 3362, 2966, 1732, 1673 cm–1; 1H-NMR (CDCl3, major diastereomer)  0.65 (d, J = 6.6 Hz, 
3H), 0.75 (d, J = 6.6 Hz, 3H), 1.37 (s, 9H), 1.89–2.05 (m, J = 6.6 Hz, 1H), 2.74 (s, 6H), 2.84 (s, 1H), 
3.70 (d, J = 14.4 Hz, 1H), 3.79 (s, 3H), 4.30 (d, J = 14.4 Hz, 1H), 5.18 (s, 1H), 6.85 (d, J = 5.6 Hz, 
1H), 6.90 (br, 1H), 7.19–7.28 (m, 5H), 8.28 (d, J = 5.6 Hz, 1H), 8.47 (s, 1H); 13C-NMR (CDCl3, major 
diastereomer)  19.7, 20.4, 28.7, 44.2, 51.1, 51.3, 53.4, 60.8, 68.7, 113.3, 127.1, 128.2, 128.6, 139.4, 
149.1, 149.8, 150.3, 152.1, 159.4, 170.3, 174.8; HRMS-FAB (m/z): [M+H]+ calcd. for C26H39N4O3 
455.3022, found 455.3043. 
(1SR) N-(1-(N-tert-Butylcarbamoyl)-1-(4-(dimethylamino)pyridyn-3-yl)methyl)-L-proline methyl ester 
(4o): A yellowish solid (93.5 mg, 51% yield, d.r. 74:26); For mixture of two diastereomers: m.p.  
105–109 °C; IR (KBr) = 3276, 2967, 1734, 1663 cm–1; 1H-NMR (CDCl3, major diastereomer)  1.38 
(s, 9H), 1.69–1.87 (m, 3H), 1.99–2.09 (m, 1H), 2.27–2.33 (m, 1H), 2.76–2.81 (m, 1H), 2.87 (s, 6H), 
3.46 (dd, J = 3.6, 9.5 Hz, 1H), 3.69 (s, 3H), 4.89 (s, 1H), 6.86 (d, J = 5.6 Hz, 1H), 7.50 (br, 1H), 8.32 
(d, J = 5.6 Hz, 1H), 8.41 (s,1H); 13C-NMR (CDCl3, major diastereomer)  23.7, 28.7, 29.6, 44.6, 50.0, 
50.9, 51.7, 63.1, 63.9, 113.6, 125.4, 149.4, 151.3, 160.4, 170.7, 175.1; HRMS-FAB (m/z): [M+H]+ 
calcd. for C19H31N4O3 363.2396, found 363.2399. 
3.4. Kinetic Resolution of a Racemic Alcohol by Chiral DMAP Derivative 
To a solution of major diastereomer of 4a (3.6 mg, 0.01 mmol), 1-phenylethanol (5, 25.4 L,  
0.21 mmol) and triethylamine (21.0 L, 0.15 mmol) in toluene (0.4 mL) at –60 °C, was added acetic 
anhydride (14.0 L, 0.15 mmol) and the reaction mixture was stirred at the same temperature for 15 h. 
The reaction was quenched with methanol and concentrated in vacuo. The resulting residue was 
filtered through a short plug of silica gel (hexane/Et2O = 3:1, v/v), affording a 28% ee of (S) acetate 
and a 23% ee of unreacted (R) alcohol at 43% conversion determined by 1H-NMR analysis. The ee 
values indicate s = 2.33 at 43% conversion. HPLC (DAICEL CHIRALCEL OD-H, 0.46 cm  × 25 cm, 
hexane/isopropanol = 19:1; 0.3 mL/min; 30 °C): Rt 14.5 min (minor ester), 15.3 min (major ester),  
27.9 min (major alcohol), and 31.8 min (minor alcohol). 
3.5 X-ray Structure Report for (S,R)-4a 
CCDC 833504 contains the supplementary crystallographic data for this paper. These data can be 
obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html. 
3.5.1. Data Collection 
A colorless prism crystal of C19H32N4O3 having approximate dimensions of 0.600 × 0.080 × 0.060 mm 
was mounted on a glass fiber. All measurements were made on a Rigaku Saturn724 diffractometer 
using multi-layer mirror monochromated Mo-Ka radiation. The data were collected at a temperature of 
−179 ± 1 °C to a maximum 2q value of 55.0°. A total of 1440 oscillation images were collected. A 
sweep of data was done using w oscillations from −110.0 to 70.0° in 0.5° steps. The exposure rate was 
20.0 [s/°]. The detector swing angle was −19.76°. A second sweep was performed using w oscillations 
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from −110.0 to 70.0° in 0.5° steps. The exposure rate was 20.0 [s/°]. The detector swing angle was 
−19.76°. Another sweep was performed using w oscillations from −110.0 to 70.0° in 0.5° steps. The 
exposure rate was 20.0 [s/°]. The detector swing angle was −19.76°. Another sweep was performed 
using w oscillations from −110.0 to 70.0° in 0.5° steps. The exposure rate was 20.0 [s/°]. The detector 
swing angle was −19.76°. The crystal-to-detector distance was 44.98 mm. Readout was performed in 
the 0.141 mm pixel mode (Table 6). 
Table 6. Crystal data and structure refinement for ydkr. 
Empirical formula  C19 H32 N4 O3 
Formula weight  364.49 
Crystal Color, Habit colorless, needle 
Temperature  93(2) K 
Wavelength  0.71075 Å 
Crystal system  orthorhombic 
Space group  P21212 (#18) 
Unit cell dimensions a = 17.791(6) Å a = 90° 
b = 17.955(6) Å b = 90° 
c = 6.363(2) Å g = 90° 
Volume 2032.6(11) Å3 
Z 4 
Density (calculated) 1.191 Mg/m3 
Absorption coefficient 0.082 mm−1 
F(000) 792 
Crystal size 0.60 × 0.08 × 0.06 mm3 
Theta range for data collection 3.22 to 27.49°. 
Index ranges −23 ≤ h ≤ 23, −23 ≤ k ≤ 23, −8 ≤ l ≤ 8 
Reflections collected 31451 
Independent reflections 4665 [R(int) = 0.0603] 
Completeness to theta = 27.49° 99.60% 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4665 / 816 / 487 
Goodness-of-fit on F2 0.966 
Final R indices [I > 2sigma(I)] R1 = 0.0471, wR2 = 0.1109 
R indices (all data) R1 = 0.0619, wR2 = 0.1202 
Absolute structure parameter 0.1(12) 
Extinction coefficient 0.024(3) 
Largest diff. peak and hole 0.228 and −0.238 e.Å−3 
3.5.2. Data Reduction 
Of the 31,451 reflections that were collected, 4,665 were unique (Rint = 0.0603); equivalent 
reflections were merged. Data were collected and processed using CrystalClear (Rigaku) [36]. 
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3.5.3. Structure Solution and Refinement 
The structure was solved by direct methods [37] and expanded using Fourier techniques. The  
non-hydrogen atoms were refined anisotropically. Hydrogen atoms were refined using the riding 
model. The final cycle of full-matrix least-squares refinement [38] on F [39] was based on 4665 
observed reflections and 236 variable parameters and converged (largest parameter shift was 0.00 
times its esd) with unweighted and weighted agreement factors of: 
R1 = S ||Fo| − |Fc|| / S |Fo| = 0.0471 
wR2 = [S(w (Fo2 – Fc2)2)/ S w(Fo2)2]1/2 = 0.1109 
The standard deviation of an observation of unit weight [40] was 1.50. Unit weights were used. The 
maximum and minimum peaks on the final difference Fourier map corresponded to 1.48 and  
−0.80 e−/Å3, respectively. The absolute structure was deduced based on Flack parameter, −2(4), using 
1983 Friedel pairs [41]. 
Neutral atom scattering factors were taken from Cromer and Waber [42]. Anomalous dispersion 
effects were included in Fcalc [43]; the values for Df' and Df" were those of Creagh and McAuley [44]. 
The values for the mass attenuation coefficients are those of Creagh and Hubbell [45]. All calculations 
were performed using the Yadokari-XG 2009 [46] crystallographic software package except for 
refinement, which was performed using SHELXL-97 [47]. 
4. Conclusions 
We have studied the diastereoselective Ugi reactions of DMAP-based aldehydes with -amino 
acids and tert-butyl isocyanide. The reactions of 4-(dimethylamino)-2-pyridinecarboxaldehyde (1) 
with various -amino acids as a chiral source proceeded to afford the desired Ugi products 2a–h in 
moderate to high yield (19%–98%) with low diastereoselectivity ratio (50:50–63:37; d.r.), even though 
various -amino acids structures were investigated. On the other hand, the reactions of  
4-(dimethylamino)-3-pyridinecarboxaldehyde (3) with various -amino acids delivered the desired 
Ugi products 4a–o in moderate yield (18%–63%) with high diastereoselectivity (up to 93:7 d.r.). The 
fact that the combination of α-amino acid and 3-formyl DMAP is critical to achieve high 
diastereoselectivity is noteworthy. We also demonstrated that the kinetic resolution of racemic alcohol 
5 using a major diastereomer of the Ugi product 4a as a catalyst afforded enantioenriched acetylated 
product 6 and unreacted alcohol 5 with a selectivity factor of 2.33. The result indicated that the  
Ugi products are potential chiral nucleophilic catalysts. Further optimization of the catalyst structure 
and the application of these catalysts to other important asymmetric transformations are currently  
in progress. 
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